推荐产品
生物源
mouse
品質等級
抗體表格
purified immunoglobulin
抗體產品種類
primary antibodies
無性繁殖
hT2H21F11, monoclonal
物種活性
human, mouse
技術
ChIP: suitable
immunoprecipitation (IP): suitable
western blot: suitable
同型
IgG1κ
NCBI登錄號
UniProt登錄號
運輸包裝
wet ice
目標翻譯後修改
unmodified
基因資訊
human ... TET2(54790)
一般說明
甲基胞嘧啶双加氧酶TET2催化甲基胞嘧啶（5mC）向5-羟甲基胞嘧啶（5hmC）的转化。目前尚不清楚5-羟甲基胞嘧啶的功能，但它可能影响染色质结构，或充当胞嘧啶去甲基化的中间成分。TET2经常在骨髓增生性疾病(MPD)或骨髓增生性肿瘤(MPN)和全身性肥大细胞增多症中发生突变。TET2疾病还会引起真性红细胞增多症(PV)和骨髓增生异常综合症(MDS)。
特異性
该抗体识别TET2的N末端
免疫原
对应于人TET2 N末端的重组蛋白。
應用
使用该小鼠单克隆抗体（抗TET2抗体，克隆hT2H 21F11）检测Tet2，该抗体经验证可用于染色质IP（ChIP）和蛋白质印迹& IP。
蛋白质印迹分析：1.0 µg/mL的代表性批次在10 µg TF-1细胞裂解物中检测到TET2。
免疫沉淀分析：5 µg的代表性批次在250 µg HL60 RIPA细胞裂解物中免疫沉淀TET2。
免疫沉淀分析：5 µg的代表性批次在250 µg HL60 RIPA细胞裂解物中免疫沉淀TET2。
品質
通过蛋白质印迹法在MOLT-4细胞裂解物中进行评价。
蛋白质印迹分析：1.0 µg/mL的该抗体在10µg MOLT-4细胞裂解物中检测到TET2。
蛋白质印迹分析：1.0 µg/mL的该抗体在10µg MOLT-4细胞裂解物中检测到TET2。
標靶描述
观测分子量〜260 kDa。该蛋白的计算分子量为224 kDa，但可在约260 kDa处观察到
外觀
形式：纯化
分析報告
对照
MOLT-4细胞裂解物
MOLT-4细胞裂解物
其他說明
浓度：关于批次特定浓度请参见检验报告。
未找到合适的产品？
试试我们的产品选型工具.
儲存類別代碼
12 - Non Combustible Liquids
水污染物質分類（WGK）
WGK 1
閃點（°F）
Not applicable
閃點（°C）
Not applicable
Lorenzo de la Rica et al.
Genome biology, 14(9), R99-R99 (2013-09-14)
DNA methylation is a key epigenetic mechanism for driving and stabilizing cell-fate decisions. Local deposition and removal of DNA methylation are tightly coupled with transcription factor binding, although the relationship varies with the specific differentiation process. Conversion of monocytes to
Yueyue Duan et al.
Journal of medical virology, 94(7), 3251-3256 (2022-02-26)
Swine acute diarrhea syndrome coronavirus (SADS-CoV) is a newly discovered bat-origin coronavirus with fatal pathogenicity for neonatal piglets. There is no vaccine to prevent SADS-CoV infection or clinically approved drugs targeting SADS-CoV. Therefore, unraveling cellular factors that regulate SADS-CoV for
Yan-Ping Xu et al.
The Journal of clinical investigation, 130, 4316-4331 (2019-07-17)
Loss-of-function mutations in genes encoding TET DNA dioxygenase occur frequently in hematopoietic malignancy, but rarely in solid tumors which instead commonly have reduced activity. The impact of decreased TET activity in solid tumors is not known. Here we show that
Yundong He et al.
Nature communications, 12(1), 1521-1521 (2021-03-23)
Resistance to next-generation anti-androgen enzalutamide (ENZ) constitutes a major challenge for the treatment of castration-resistant prostate cancer (CRPC). By performing genome-wide ChIP-seq profiling in ENZ-resistant CRPC cells we identify a set of androgen receptor (AR) binding sites with increased AR
Eevi Kaasinen et al.
Nature communications, 10(1), 1252-1252 (2019-03-21)
Clonal hematopoiesis driven by somatic heterozygous TET2 loss is linked to malignant degeneration via consequent aberrant DNA methylation, and possibly to cardiovascular disease via increased cytokine and chemokine expression as reported in mice. Here, we discover a germline TET2 mutation
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门